secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIM ImmunoTech Inc. (AIM)
CIK:        0000946644
Form:       8-K
Filed at:   2026-06-15T12:01:16+00:00
Accession:  0001493152-26-028615
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AIM ImmunoTech regains NYSE American listing compliance after equity deficiency resolved
--------------------------------------------------------------------------------

- Received NYSE American notice on June 12, 2026 that it resolved stockholders' equity deficiencies under Sections 1003(a)(i)-(iii).
- Raised ~$8.5M total through warrant exercises and stock sales: $3.5M (May 7 warrant inducement), $2.4M (May 21 placement), $2.6M (June 10 placement).
- Issued over 10M shares and warrants; believes stockholders' equity now exceeds $6M minimum requirement.
- ".BC" indicator to be removed from trading symbol (AIM); company removed from NYSE American noncompliant list.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/946644/000149315226028615/0001493152-26-028615-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/946644/000149315226028615/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-028615

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer